Skip to main content

Pitfalls of FDA’s Breakthrough Drug Program

Posted in News on 4.17.2018

While the FDA’s expedited review programs are often touted as a way of speedily getting life-saving or life-altering drugs into the hands of patients in need, some experts, among them Alosa Health founder Jerry Avorn, are skeptical about the FDA’s breakthrough drug therapy (BTD) program....


Congenital Syphilis Program in Maryland Underway

Posted in Updates on 3.23.2018

After winning a bid to provide educational outreach services in the city of Baltimore, Alosa Health has partnered with Maryland Department of Health to develop educational training materials on the topic of congenital syphilis prevention and to deploy a field-based educational program. Rates of cong...


JAMA Study Challenges Efficacy of Opioids vs Non-addictive Alternatives

Posted in News on 3.21.2018

For some time now the medical community has sought guidance on responsible prescribing related to opioids. A large, randomized trial, recently published in JAMA, demonstrated that for patients with moderate-to-severe chronic back pain or hip or knee osteoarthritis pain, a non-opioid medication regim...


Psychology of Clinical Decision Making

Posted in News on 2.26.2018

In a Perspective piece published earlier this week in the New England Journal, Alosa Health Founder and Clinical Advisor Dr. Jerry Avorn discusses the science of decision-making. While the science of decision-making is a well-developed field, its application to the field of medicine has been slow. ...


Contract Expansion Targets Opioid Epidemic in Pennsylvania

Posted in Updates on 1.11.2018

Alosa Health’s contract with Pennsylvania's Pharmaceutical Assistance Contract for the Elderly (PACE) expands thanks to a $26.5 million federal grant awarded to the State of Pennsylvania to combat the opioid epidemic. The funding will allow Alosa to visit more PA physicians to provide...


PACE Introduces Chronic Pain Module

Posted in Updates on 12.14.2017

Alosa Health has just released an updated Chronic Pain module through Pennsylvania’s PACE program. This educational program presents the most recent evidence for effectively treating pain in the elderly. The emphasis is on non-pharmacologic and non-opioid pharmacologic options, with the goal o...


Talking to Patients About Health Policy

Posted in News on 12.14.2017

Alosa Health founder and clinical consultant Dr. Jerry Avorn offered an opinion in the Journal of the Medical American Association’s (JAMA’s) essay feature on the topic of engaging patients in health policy talk.   The question of whether clinicians should interact with their ...


Academic Detailing to Combat Opioids in Northern California

Posted in News on 11.17.2017

Kasier Health News recently reported that money from Obama-era grants is being used to fund academic detailing programs in California for the purpose of educating providers on the risks of prescribing opioids. To date, academic detailing programs has been used to address overprescribing of opioids a...


Academic Detailing Conference Inspires

Posted in Updates on 11.9.2017

Earlier this week members of the Alosa Health team attended the 5th International Conference on Academic Detailing, hosted by our friends and colleagues at NaRCAD. The conference is always an amazing opportunity to connect with others doing academic detailing work and to share insights and best prac...


Executive Director Testifies at Senate Committee Hearing

Posted in Updates on 10.25.2017

This week Alosa Health Executive Director Paul Fanikos testified at the Special Senate Committee Hearing on Health Care Cost Containment and Reform in support of investing in an evidence-based educational outreach program. During the testimony, Fanikos explained how a program focused on therapeutic ...